Skip to main content

Rectal cancer drug trial of dostarlimab cures all patients: report

A clinical trial of dostarlimab, done by Memorial Sloan Kettering Cancer Center, found the drug appears to have completely cured 12 patients of rectal cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.